Kindbody Turns Benefits Into Care Delivery

Vertical integration is turning fertility benefits from a referral business into a care delivery business. Kindbody already sells employers a combined package of owned clinics, IVF labs, virtual support, and benefits administration, while Maven is adding tighter clinic network controls inside its wallet product. The practical difference is who captures the treatment dollar, who controls the patient experience, and who can steer members into a preferred network instead of handing them off to outside providers.

• Kindbody is furthest along on the clinic to benefits path. By June 2025 it had 27 owned clinics and IVF labs, 400 plus partner clinics across 113 countries, and 135 employers. That lets it sell one employer contract that covers navigation, authorizations, virtual support, and actual in clinic treatment.
  1 sacra 3 sacra 4 kindbody
• Maven is moving the other direction. It remains virtual first, but its 2024 materials describe 17.5M covered lives and a global clinic network, and in early 2026 it launched a Clinic Finder and required certain wallet users to use Maven Partner Clinics. That is benefits infrastructure becoming narrower network design.
  5 sacra 6 mavenclinic 7 mavenclinic
• The economic logic is clear in the margin spread. Progyny generated $1.17B of 2024 revenue at roughly 21% gross margin because much of the IVF spend passes through to outside providers. Kindbody has been estimated near 60% gross margin because it owns more of the underlying care stack.
  3 sacra 8 progyny 9 kindbody

The next phase is likely a split market. Asset light platforms will keep winning multinational, broad women’s health accounts, while clinic backed players will push harder into narrow networks and owned delivery where they can prove lower cost and tighter outcomes. Fertility benefits will increasingly look like managed care with branded front doors, not just reimbursement wrapped in care navigation.